Anduril Keeps Winning Billion-Dollar Contracts and You Can't Buy It. Here Are 3 Public Stocks That Get Paid Alongside It.

Anduril is a military technology company that aims to modernize the U.S. military's supply chain. It recently secured $5 billion in funding at a $61 billion valuation to expand its manufacturing of drones, submarines, and other defense technology. However, buying shares in Anduril is nearly impossible for individual investors as the company remains privately held. Here are three publicly traded companies that stand to benefit from Anduril's growth and could be attractive investment options.

First, Kraken Robotics (PNG) is a small-cap company that provides components for modern submarine and underwater drone technologies. They manufacture insulated batteries, sensors, sonar equipment, and other essential components for defense contractors like Anduril. With the increasing difficulty of securing ocean commerce due to modern drone technology, Kraken has an opportunity to grow significantly. In 2026, the company expects to generate over $300 million in revenue, making it a promising investment option.

Next, Archer Aviation (ACHR) is a company specializing in the development of electric vertical takeoff and landing (eVTOL) aircraft for military applications, a partnership with Anduril. Although Archer Aviation's commercial eVTOL is still in the approval process, the company's growth is brimming with potential. Their upfront investments are resulting in significant cash burn, leading to a current free cash flow of -$681 million.

Despite this, Archer Aviation's riskier nature should be weighed against the more stable and established growth of Kraken Robotics.

Lastly, Karman Holdings (KRMN) is a defense subcontractor that provides components to help maintain structural integrity in extreme heat and harsh operating environments for missiles and rockets. As Anduril aims to disrupt the traditional missile supply chain and manufacture its own interceptors, Karman Holdings will experience increased demand for its products.

With a steady revenue growth rate of 24.4% and a substantial backlog of $1.3 billion, Karman Holdings is a solid investment choice. However, its premium valuation at a price-to-sales ratio of 7 could fluctuate if the company continues to grow rapidly.